Kybella: FDA-Approved Injectable for Double Chin Reduction

Kybella is a nonsurgical injectable treatment that permanently reduces submental fat, commonly known as a double chin. Approved by the U.S. Food and Drug Administration in 2015, it remains the only FDA-approved injectable specifically designed to improve the appearance of moderate to severe fat below the chin. Each treatment session takes approximately 15 to 20 minutes and requires no incisions or general anesthesia.

What Kybella Is and How It Works

Kybella uses synthetic deoxycholic acid to destroy fat cells beneath the chin, producing long-lasting results without surgery.

The active ingredient in Kybella is synthetic deoxycholic acid, a molecule naturally produced by the body to aid in the digestion and absorption of dietary fat. When injected into the submental area, deoxycholic acid disrupts fat cell membranes, causing them to break down. The body then metabolizes these destroyed cells over the following weeks.

Once the fat cells in the treatment area are eliminated, they cannot regenerate or store fat again. According to the official Kybella prescribing information, further treatment is not expected once a patient achieves their desired aesthetic result. This permanent mechanism sets Kybella apart from many other non-surgical contouring treatments that offer only temporary improvement.

Kybella is manufactured by Allergan Aesthetics, an AbbVie company, and is commercially available under the brand name KYBELLA. The treatment is FDA-approved exclusively for submental fat and is not indicated for fat reduction in other areas of the face or body. Patients under 18 years of age are not candidates for this treatment.

Ideal Candidates for Kybella Treatment

Adults with moderate to severe submental fat who prefer a nonsurgical option are the best candidates for Kybella.

A double chin can develop from a combination of genetics, age, and anatomy, regardless of overall body weight. A 2015 consumer survey by the American Society for Dermatologic Surgery found that 67 percent of individuals report being bothered by excess fat under the chin or neck. Kybella addresses this concern directly for patients who have not achieved results through diet and exercise alone.

Candidates should not have an active infection in the treatment area. Patients who have undergone previous surgery or cosmetic procedures on the face, neck, or chin must disclose this history to their provider. Kybella is not recommended for individuals who are pregnant, breastfeeding, or planning to become pregnant, as its effects on fetuses and infants have not been fully established. Those with bleeding disorders or difficulty swallowing should also discuss these conditions before proceeding.

For readers researching related nonsurgical aesthetic topics, the article on Bellafill dermal filler covers another long-lasting injectable option used for facial rejuvenation and acne scar treatment.

The Kybella Treatment Process

A trained healthcare specialist administers 20 to 50 small injections under the chin per session, with sessions spaced at least one month apart.

Before the procedure, the provider marks the injection sites with a medical marker and may apply a topical numbing agent or ice pack to minimize discomfort. The injection grid is precisely mapped to the distribution of submental fat in each individual patient. This customized approach is important because deoxycholic acid can affect surrounding tissue if not administered correctly.

Each treatment session involves between 20 and 50 injections, depending on the volume and distribution of fat beneath the chin. The process takes 15 to 20 minutes from start to finish. Patients may receive up to six treatment sessions, with a mandatory minimum interval of one month between each session.

Expected Results and Number of Sessions

Most patients see visible results after two to four sessions, though 59 percent of clinical study participants received the full six treatments.

Results from Kybella emerge gradually as the body metabolizes the destroyed fat cells over several weeks. According to clinical data published by the manufacturer, many patients achieve visible contouring in the submental area after two to four treatment sessions. In clinical studies, 82.4 percent of patients reported significantly improved satisfaction with their facial profile following treatment.

The number of sessions required varies based on the amount of submental fat present and each patient’s individual treatment goals. Some patients reach their desired outcome in two or three sessions, while others benefit from the maximum six. The treating specialist will develop a personalized plan during the initial consultation.

Readers interested in evidence-based aesthetic treatments may also find the overview of lipopeptides and emerging biological signaling research informative as a complement to understanding how cell-targeting compounds work.

Side Effects and Safety Considerations

Common side effects include swelling, bruising, pain, numbness, and redness, which typically resolve within one to two weeks.

Kybella has a well-established safety profile based on more than 20 clinical studies involving over 1,600 patients. The most frequently reported side effects are localized to the injection site and include swelling, bruising, pain, numbness, and areas of firmness under the chin. These reactions are expected and generally subside within one to two weeks after treatment.

Rare but serious side effects have been reported, including nerve injury in the jaw that can cause an uneven smile or temporary facial muscle weakness, difficulty swallowing, and tissue damage around the injection site. According to the FDA prescribing information for Kybella, patients should contact their healthcare provider immediately if they experience facial muscle weakness, an asymmetric smile, or worsening difficulty swallowing. These risks are minimized when treatment is administered by a properly trained specialist.

Kybella is not recommended for patients with an active infection in the submental area. Blood thinners and anticoagulant medications can increase bruising risk and should be disclosed to the provider before the procedure.

Cost and Insurance Coverage

Kybella costs between $1,200 and $1,800 per treatment session and is not covered by health insurance as it is classified as a cosmetic procedure.

The total cost of Kybella treatment depends on the number of sessions required, the provider’s fee structure, and geographic location. Patients who need the full six sessions should budget accordingly before beginning treatment. The Alle loyalty program, offered by Allergan Aesthetics, provides points and savings on Kybella and other select treatments.

Kybella Compared to Surgical Alternatives

Kybella offers a nonsurgical alternative to liposuction and neck lift procedures, with lower downtime and fewer procedural risks.

Before Kybella received FDA approval, surgical options such as liposuction, fat excision, and neck lifts were the primary methods for addressing submental fullness. These procedures require anesthesia, carry risks of infection and scarring, and involve longer recovery periods. Kybella requires no incisions and minimal downtime, with most patients returning to normal activities within a few days.

Patients with larger volumes of submental fat or significant skin laxity in the neck area may be better served by surgical intervention. According to plastic surgery specialists at MedStar Health, some patients benefit from combining Kybella with other procedures such as a neck lift to achieve optimal contouring. A thorough consultation with a board-certified specialist helps determine the most appropriate treatment plan.

For readers exploring broader research on treatment-focused topics, the article on drug repurposing in current studies provides context on how approved compounds continue to be evaluated for expanded applications.

Finding a Qualified Kybella Provider

Kybella must be administered by a trained healthcare specialist; the official provider locator at MyKybella.com helps patients find credentialed practitioners.

Because deoxycholic acid can damage surrounding tissue if injected imprecisely, selecting a trained and experienced provider is a primary factor in treatment safety and outcome. Dermatologists, plastic surgeons, and licensed aesthetic practitioners who have completed Kybella-specific training are qualified to administer the treatment.

Patients should request a consultation before committing to treatment. During the consultation, the provider evaluates submental fat distribution, skin laxity, and overall candidacy to determine whether Kybella is the right approach and how many sessions will likely be needed.